Active Filter(s):
Details:
Eurofins acquired Beacon Discovery for its innovative approach, years of experience in drug discovery and development as well as their profound expertise in GPCR research, complemented by their unique compound library.
Lead Product(s): Undisclosed
Therapeutic Area: Technology Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Small molecule
Recipient: Beacon Discovery
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition February 18, 2021